Welcome to States of Play
State boards that aim to limit what health plans pay for prescription drugs are pressing ahead with their work as Colorado’s panel battles what’s expected to be the first in a long line of drug industry suits. And California has emerged as the front line in the battle over regulating artificial intelligence. Keep reading for more on the policies shaping the nation.
Forwarded this newsletter by a friend? SIGN UP HERE
Analysts predict a flood of pharmaceutical industry lawsuits against state drug boards, but the possibility of challenges hasn’t stopped the boards from moving forward with ...